Tysabri review launched in Europe
Tysabri review launched in Europe
In light of growing evidence, the European Medicines Agency (EMA) has been asked to launch a review of the multiple sclerosis drug Tysabri to assess whether advice on managing known risks for progressive multifocal leukoencephalopathy (PML) should be revised.... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1951 Views
-
Last post by frodo
-
- 0 Replies
- 1326 Views
-
Last post by NHE
-
- 0 Replies
- 1700 Views
-
Last post by frodo
-
- 0 Replies
- 1251 Views
-
Last post by frodo
-
- 1 Replies
- 1801 Views
-
Last post by frodo
-
- 0 Replies
- 2119 Views
-
Last post by NHE
-
- 0 Replies
- 995 Views
-
Last post by frodo
-
- 0 Replies
- 1080 Views
-
Last post by frodo
-
- 1 Replies
- 1525 Views
-
Last post by NHE